CompoAtlas

Luminaissance + fruits exotique

Food supplement declared in France, decision dated 23 June 2025

Luminaissance + fruits exotique (Imane Harmonie) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: inositol 4,000 mg per day, taurine 395 mg per day, acétylcystéine 190 mg per day, Folate (vitamin B9), Vitamin B12. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Imane Harmonie
Food business operator placing the product on the market
Imane Harmonie
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
5 g par jour
Directions for use
UNE CUILLIERE DE 5 GRAMMES LE MATIN DANS UN GRAND VERRE D'EAU
Intended populations
General population
Not recommended (according to the manufacturer)
Children (under 12), Kidney failure
Objectives stated by the manufacturer (these are not authorised claims)
Autre : réduire la fatigue, activité hormonale, Immunité
Flavourings
Fruits exotique

Declaration 332928, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Substances

NamePer day
inositol4,000 mg
taurine395 mg
acétylcystéine190 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
(6S)-5-methyltetrahydrofolic acid, glucosamine saltFolate (vitamin B9)1,000 µg200 µg
methylcobalaminVitamin B12no adverse effect defineddose annulled by the French Council of State in 2011
pyridoxal 5′-phosphateVitamin B612 mg2 mg
L-ascorbic acidVitamin Cno limit (insufficient data)180 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

NE PAS DÉPASSER LA DOSE JOURNALIÈRE RECOMMANDÉE, TENIR HORS DE PORTÉE DES ENFANTS, NE SE SUBSTITUE PAS À UNE ALIMENTATION VARIÉE DÉCONSEILLÉ EN CAS D'ALLERGIE À L'UN DES COMPOSANTS. NE PAS ADMINISTRER À DES ENFANTS DE MOINS DE 12 ANS. INFORMER VOTRE MÉDECIN OU PHARMACIEN EN CAS DE PRISE SIMULTANÉE DE MÉDICAMENTS. DÉCONSEILLÉ EN CAS DE GROSSESSE ET D'INSUFFISANCE RÉNALE.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • acétylcystéine
    Read the warning, when it applies and the studies cited

    N-ACETYL-L-CYSTEINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).

    Sources cited by Health Canada (2)
    • Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
    • Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed

    Contraindications

    Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).

    Sources cited by Health Canada (4)
    • Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
    • Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
    • Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
    • Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Imane Harmonie

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Luminaissance + fruits exotique (Imane Harmonie): composition and regulation”, https://compoatlas.com/en/supplements/products/332928-luminaissance-fruits-exotique, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line